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Actinomyces gerencseriae hip prosthesis
infection: a case report
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Abstract
Introduction: Actinomyces bacteria are part of the human oropharyngeal microbiota. They have been associated
with abdominal, cervicofacial and thoracic infections and a few cases of joint infections have also been described.
In particular, Actinomyces gerencseriae, formerly described as Actinomyces israelii serovar II, has rarely been associated
with human infections, mostly involving cervicofacial lesions and periodontal diseases. Here, we report one case of
hip prosthesis infection due to A. gerencseriae.
Case presentation: A 72-year-old Caucasian male developed an inflammatory collection on the outside of the right
thigh where a hip prosthesis had been implanted for 11 years. Culturing a fluid sample from the collection puncture
found Staphylococcus hominis and a Gram-positive bacillus unidentified by matrix-assisted laser desorption ionization
time-of-flight mass-spectrometry (MALDI-TOF). Sequencing the 16S rRNA gene amplified from both the specimen and
the isolate identified A. gerencseriae. Treatment adjusted with amoxicillin and trimethropim-sulfamethoxazole cured the
infection.
Conclusion: The recently described A. gerencseriae has rarely been involved in human infections. We report the first
case of A. gerencseriae joint infection in a hip prosthesis.
Keywords: Actinomyces gerencseriae, Infection, Orthopedic device, Hip prosthesis
Introduction
Actinomyces bacteria are commensal members of the of
oropharynx [1], digestive tract [2] and urogenital tract
microbiota [3]. As pathogens, they are responsible for
cervicofacial lesions [4], abdominopelvic infections [5]
and respiratory tract infections [6]. Actinomyces bacteria
have rarely been reported as being responsible for
central nervous system (CNS) infections, skin infections
[7] and bone and joint infections [7]. In this genus,
Actinomyces israelii serovar II has been reclassified as
Actinomyces gerencseriae, a commensal member of the
human oral flora [8]; being further associated with cervi-
cofacial infections [4], dental diseases [9, 10], in cases of
osteoradionecrosis [11], but very rarely causing infection
at other sites [12].
Here, we describe the first case of hip prosthesis infec-
tion due to this microorganism.
Case presentation
A 72-year-old Caucasian male was diagnosed with an in-
fected periprosthetic hematoma of the right hip. His
medical history included bilateral osteoarthritis cured by
the implantation of a right hip prosthesis 11 years previ-
ously and a left hip prosthesis four years previously,
along with three myocardial infarctions followed by the
implantation of ten coronary artery stents and the recent
implantation of an implantable cardiac defibrillator
(ICD) and consecutive warfarin treatment. Overdosage
of the latter drug caused a right iliopsoas hematoma.
Over the following three months, the patient presented
with Guillain-Barré syndrome, which rapidly resolved
after the administration of immunoglobulins, and angio-
cholitis cured by the administration of amoxicillin-
clavulanate.
At the same time, he was diagnosed with fistulization
of the infected iliopsoas hematoma on the outside of the
right thigh, which had been neglected in view of other
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intercurrent medical episodes. This was subsequently
treated for eight weeks by amoxicillin-clavulanate and
fusidic acid without microbiological documentation.
Four months later, the right hip collection persisted and
an incision with drainage was conducted. Several PCR
tests, including 16S rRNA gene amplification [13] per-
formed on the sampled fluid, were negative and the
standard culture was sterile. At that time, the white
blood cell count was normal at 8.4×109/L (the neutro-
phil count was 6.2×109/L) and the platelet count was
246×109/L. The erythrocyte sedimentation rate was
elevated at 82mm/hour. A second specimen, sampled
eight weeks later, grew two types of colonies on
Columbia agar with 5% sheep blood (bioMérieux,
Marne la Coquette, France) incubated at 37°C in a
5% CO2-enriched and anaerobic atmosphere. Matrix-
assisted laser desorption ionization time-of-flight mass-
spectrometry (MALDI-TOF-MS) [14], that allows
bacterial identification through their mass spectra,
identified one colony as Staphylococcus hominis with an
identification score of 2.02. However, MALDI-TOF-MS
identification of the second colony failed. This Gram-
positive bacillus was then identified by PCR-sequencing
of the 16S rRNA gene as previously described [13]. A
1,486-bp sequence (GenBank LN624398) yielded 99.2%
similarity with A. gerencseriae (Genbank X80414) using
NCBI BLAST (http://www.ncbi.nlm.nih.gov). This isolate
was deposited in the Collection de Souches de l’Unité
des Rickettsies (=CSUR P1401). This A. gerencseriae
MALDI-TOF-MS spectrum was subsequently added to
the database (Fig. 1) in order to be specifically com-
pared to eight other Actinomyces spectra available in
the database (Fig. 2). Further amplification and se-
quencing of the 16S rRNA gene directly on the sam-
pled fluid yielded a 999-bp sequence exhibiting 98.9%
sequence similarity with A. gerencseriae (Genbank
NR029280) and 99.7% sequence similarity with that of
the isolate (GenBank LN624398). The antibiotic regimen
was adapted with amoxicillin and trimethoprim-
sulfamethoxazole after the minimum inhibitory concen-
trations had been measured at 0.023mg/L and <1mg/L,
respectively. This treatment was stopped three weeks
later due to kidney failure. Further microbiological inves-
tigation found Staphylococcus aureus and ofloxacin com-
bined with rifampicin was finally prescribed.
This patient presented a mixed infection of a hip pros-
thesis with A. gerencseriae being one of the three docu-
mented organisms. The presence of this organism was
definitively confirmed by two different techniques. Thus,
direct 16S rRNA gene amplification in a puncture
product strengthened the culture results, excluding
laboratory contamination and indicating that the
microorganism was indeed present in the collected
specimen. Moreover, A. gerencseriae [8] inhabits the
Fig. 1 Reference mass spectrum from A. genrencseriae strain URMITE (= CSUR P1401). Spectra from 12 individual colonies were compared and a
reference spectrum was generated
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human oral microbiota [15] but not human skin, ren-
dering the probability of per-operative contamination
highly improbable. Also, A. genrencseriae is not known as
a laboratory contaminant and we had no other case
documented in our laboratory. Therefore, we interpreted
A. genrencseriae as being part of a mixed hip prosthesis
infection in this patient.
In this case, A. genrencseriae was firmly identified
on the basis of two independent 16S rRNA gene
PCR amplifications and sequencing which yielded the
identical partial 16S rRNA gene sequence. However,
MALDI-TOF-MS identification failed since A. gen-
rencseriae was not incorporated into the commercial
database we used; accordingly, we added its spectrum
in order to allow for its subsequent identification by
MALDI-TOF-MS.
Although the species A. genrencseriae has been known
for 25 years, it has been implicated only rarely in infec-
tions, mainly head and neck infections including peri-
odontal disease [9], cervicofacial infected lesions [4],
mandibular osteoradionecrosis [12], ulcerative gingivitis
(NUG) and oral inflammatory lesions [10]. Involvement
in eye infections and chronic granulomatous diseases
has also been reported [12].
Conclusions
A. genrencseriae is a fastidious organism [15] whose
identification still requires 16S rRNA gene sequencing,
pending incorporation of the appropriate spectrum in
MALDI-TOF-MS databases. These particularities ex-
plain why very few cases of A. genrencseriae infection
have been reported. The case reported here indicates
that A. genrencseriae infections are by no means limited
to head and neck infections.
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